160 related articles for article (PubMed ID: 24054867)
21. Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury.
Chen F; Zhang G; Cao Y; Payne R; See WA
J Urol; 2007 Nov; 178(5):2166-70. PubMed ID: 17870116
[TBL] [Abstract][Full Text] [Related]
22. Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways.
Girouard J; Belgorosky D; Hamelin-Morrissette J; Boulanger V; D'Orio E; Ramla D; Perron R; Charpentier L; Van Themsche C; Eiján AM; Bérubé G; Reyes-Moreno C
Biochem Pharmacol; 2020 Jun; 176():113778. PubMed ID: 31877271
[TBL] [Abstract][Full Text] [Related]
23. Enhanced formation of nitric oxide in bladder carcinoma in situ and in BCG treated bladder cancer.
Hosseini A; Koskela LR; Ehrén I; Aguilar-Santelises M; Sirsjö A; Wiklund NP
Nitric Oxide; 2006 Dec; 15(4):337-43. PubMed ID: 16517187
[TBL] [Abstract][Full Text] [Related]
24. [Study on Toll-like receptors expression and cytokine production induced by bacillus Calmette-Guerin in human bladder cancer cell].
Li X; Gong ZY; Li H; Wei Q; Shi M; Yang YR
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):177-81. PubMed ID: 15062066
[TBL] [Abstract][Full Text] [Related]
25. The regulatory effects of polyporus polysaccharide on the nuclear factor kappa B signal pathway of bladder cancer cells stimulated by Bacillus Calmette-Guerin.
Wei JA; Zeng X; Han L; Huang Y
Chin J Integr Med; 2011 Jul; 17(7):531-6. PubMed ID: 21725879
[TBL] [Abstract][Full Text] [Related]
26. Bacillus Calmette-Guerin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells.
Morcos E; Jansson OT; Adolfsson J; Ehrén I; Wiklund NP
J Urol; 2001 Feb; 165(2):678-82. PubMed ID: 11176457
[TBL] [Abstract][Full Text] [Related]
27. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
28. Enhanced aggressiveness of bystander cells in an anti-tumor photodynamic therapy model: Role of nitric oxide produced by targeted cells.
Bazak J; Fahey JM; Wawak K; Korytowski W; Girotti AW
Free Radic Biol Med; 2017 Jan; 102():111-121. PubMed ID: 27884704
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of protein kinase Cδ inhibits inducible nitric oxide synthase expression through IRF1.
Leppänen T; Korhonen R; Laavola M; Nieminen R; Tuominen RK; Moilanen E
PLoS One; 2013; 8(1):e52741. PubMed ID: 23326354
[TBL] [Abstract][Full Text] [Related]
30. Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model.
Belgorosky D; Girouard J; Langle YV; Hamelin-Morrissete J; Marino L; Agüero EI; Malagrino H; Reyes-Moreno C; Eiján AM
J Mol Med (Berl); 2020 Nov; 98(11):1615-1627. PubMed ID: 32955679
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kappaB signaling cascade.
Vaillancourt F; Morquette B; Shi Q; Fahmi H; Lavigne P; Di Battista JA; Fernandes JC; Benderdour M
J Cell Biochem; 2007 Apr; 100(5):1217-31. PubMed ID: 17031850
[TBL] [Abstract][Full Text] [Related]
32. Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis.
Kankuri E; Hämäläinen M; Hukkanen M; Salmenperä P; Kivilaakso E; Vapaatalo H; Moilanen E
Scand J Gastroenterol; 2003 Feb; 38(2):186-92. PubMed ID: 12678336
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer.
Cianchi F; Cortesini C; Fantappiè O; Messerini L; Sardi I; Lasagna N; Perna F; Fabbroni V; Di Felice A; Perigli G; Mazzanti R; Masini E
Clin Cancer Res; 2004 Apr; 10(8):2694-704. PubMed ID: 15102673
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide synthase gene and protein expression are upregulated by Bacille Calmette-Guérin in the rat bladder.
Oh BR; Nakajima K; Ahn KY; Ryu SB; Park YI; Dahiya R
Eur Urol; 2001 Mar; 39(3):349-56. PubMed ID: 11275732
[TBL] [Abstract][Full Text] [Related]
35. Levosimendan inhibits interleukin-1β-induced apoptosis through activation of Akt and inhibition of inducible nitric oxide synthase in rat cardiac fibroblasts.
Okada M; Yamawaki H
Eur J Pharmacol; 2015 Dec; 769():86-92. PubMed ID: 26528797
[TBL] [Abstract][Full Text] [Related]
36. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages.
Kim JY; Park SJ; Yun KJ; Cho YW; Park HJ; Lee KT
Eur J Pharmacol; 2008 Apr; 584(1):175-84. PubMed ID: 18295200
[TBL] [Abstract][Full Text] [Related]
37. Expression of N-methyl D-aspartate receptor subunits in amoeboid microglia mediates production of nitric oxide via NF-κB signaling pathway and oligodendrocyte cell death in hypoxic postnatal rats.
Murugan M; Sivakumar V; Lu J; Ling EA; Kaur C
Glia; 2011 Apr; 59(4):521-39. PubMed ID: 21319220
[TBL] [Abstract][Full Text] [Related]
38. Effects of bacillus Calmette-Guèrin and interferon alpha-2B on cytokine production in human bladder cancer cell lines.
Zhang Y; Khoo HE; Esuvaranathan K
J Urol; 1999 Mar; 161(3):977-83. PubMed ID: 10022737
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cyclin-dependent kinases by olomoucine and roscovitine reduces lipopolysaccharide-induced inflammatory responses via down-regulation of nuclear factor kappaB.
Jhou RS; Sun KH; Sun GH; Wang HH; Chang CI; Huang HC; Lu SY; Tang SJ
Cell Prolif; 2009 Apr; 42(2):141-9. PubMed ID: 19250292
[TBL] [Abstract][Full Text] [Related]
40. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption.
Zheng H; Yu X; Collin-Osdoby P; Osdoby P
J Biol Chem; 2006 Jun; 281(23):15809-20. PubMed ID: 16613848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
